BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MicroDose Therapeutx (formerly MicroDose Technologies Inc) 

4262 US Route 1

Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-355-2100 Fax: 732-355-2101


SEARCH JOBS





Segment
Drug Delivery





 Company News
Teva Pharmaceutical Industries Limited (TEVA) Bags MicroDose Therapeutx (formerly MicroDose Technologies Inc) for $165 Million 6/17/2013 7:34:03 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium 9/28/2012 10:41:31 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF) 6/20/2012 11:47:28 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV) 4/24/2012 9:10:37 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Begins Phase 1 Trial of MDT-637 for Treatment of Respiratory Syncytial Virus 9/27/2011 10:40:52 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning 6/7/2011 8:39:11 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Achievement of Development Milestone Triggering a Payment Under Respiratory Collaboration 5/2/2011 9:15:13 AM
Gilead Sciences, Inc. (GILD), MicroDose Therapeutx (formerly MicroDose Technologies Inc) Ink License Deal For MDT-637 4/20/2011 8:18:53 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Nexus6 Announce Worldwide Partnership to Commercialize the SmartInhalerLiveTM Technology with MicroDose's Electronic Dry Powder Inhalers 11/9/2010 11:11:30 AM
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Awarded Four Therapeutic Discovery Grants Totaling Approximately $1 Million 11/4/2010 10:59:45 AM
123